WASHINGTON/NEW YORK (Reuters) - Democrats are showing little interest in cooperating with the Republicans who control Congress on legislation to dismantle the Obamacare health insurance law but some are signaling a willingness to collaborate on action to curb rising drug prices.
BEIJING (Reuters) - Two people in China's Anhui province have died from H7N9 bird flu, the first fatalities in China among this winter's cases, while Macau reported its first human infection of the strain since the former Portuguese colony returned to China in 1999.
LUANDA (Reuters) - Angola declared the end of the world's worst yellow fever epidemic in a generation on Friday after a U.N.-backed vaccination campaign of 25 million people that resulted in no new cases in six months.
BEIJING (Reuters) - China is set to relax regulations for foreign elderly care firms in an effort to attract investment, the State Council said in a statement issued on Friday.
ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday.
LOS ANGELES/CHICAGO (Reuters) - U.S. sales and distribution of antibiotics approved for use in food-producing animals increased 1 percent from 2014 to 2015, the U.S. Food and Drug Administration said in a report on Thursday.
AUSTIN, Texas (Reuters) - Texas plans to block about $3 million in Medicaid funding for Planned Parenthood operations in the state, a legal document obtained on Wednesday showed, a move the reproductive healthcare group said could affect nearly 11,000 low-income people.
RALEIGH, N.C. (Reuters) - North Carolina's Republican-controlled legislature on Wednesday rejected a bid to repeal a state law restricting bathroom access for transgender people, which has drawn months of protests and boycotts by opponents decrying the measure as discriminatory.
LONDON (Reuters) - Brazil should urgently review its reproductive health policies, scientists said on Friday, to support the more than 50 percent of potential mothers who say they want to avoid pregnancy due to fears about the Zika virus.
LONDON (Reuters) - A vaccine developed by Merck is the first shown to be highly effective in preventing human infection with Ebola, according to final results from a clinical trial.
No comments:
Post a Comment